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Angiotensin II regulates the synthesis of proinflammatory cyto- Angiotensin II (Ang II), the main peptide of the renin-
kines and chemokines in the kidney. angiotensin system (RAS), is considered a growth factor
Background. Emerging evidence suggests that angiotensin II that regulates cell proliferation, apoptosis and fibrosis(Ang II) is not only a vasoactive peptide, but also a true cyto-
[1–3]. Emerging information has contributed to enlargekine that regulates cell growth, inflammation and fibrosis. Many
the present view of Ang II as a proinflammatory media-studies have demonstrated that this peptide plays an active
role in the progression of renal injury. Some of Ang II-induced tor that participates in the inflammatory response in sev-
effects are mediated by the production of a large array of eral pathological processes [1]. In models of renal injury,
growth factors. The aim of this study was to investigate whether the blockade of Ang II actions, by angiotensin convertingAng II could regulate the expression of cytokines and chemo-
enzyme (ACE) inhibitors or angiotensin receptor (AT)kines in the kidney and its correlation with the Ang II-induced
antagonists, decreases proteinuria, inflammatory cell in-renal damage.
Methods. The model of Ang II-induced renal damage was filtration, fibrosis, and gene expression of matrix proteins
done by systemic Ang II infusion into normal rats (50 ng/kg/ and growth factors [1–3]. RAS blockers are commonly
min; subcutaneous osmotic minipumps). In addition, the impli-
used in the treatment of hypertension and proteinuriacation of Ang II was investigated in a model of immune com-
in humans [4].plex nephritis in rats treated with the angiotensin converting
enzyme (ACE) inhibitor quinapril. The mRNA expression was Tumor-necrosis factor (TNF-) is a proinflammatory
analyzed by RT-PCR and/or Northern blot, and protein levels cytokine with a wide variety of biological effects. TNF-
by Western blot and/or immunohistochemistry. is produced by various cell types, including proximal
Results. Rats infused with Ang II for 3 days caused elevated
tubules [5], mesangial cells [6], glomerular epithelial cellsrenal expression of tumor necrosis factor- (TNF-; gene and
[7], and endothelial cells [8], but the primary source ofprotein levels). TNF- positive cells were observed in glomeruli
(mainly in endothelial cells), tubules and vessels. In rats with this cytokine is monocytes/macrophages [9]. Elevated
immune complex nephritis, the renal overexpression of TNF- levels of renal production of TNF- have been described
was diminished by the ACE inhibitor quinapril. Systemic infu- in human and experimental nephritis [7, 10–14]. Thission of Ang II also increased renal synthesis of cytokines (in-
cytokine regulates several cellular responses, includingterleukin-6, IL-6) and chemokines (monocyte chemoattractant
cell proliferation and production of other cytokines andprotein-1; MCP-1) that were associated with elevated tissue
levels of activated nuclear factor-B (NF-B) and the presence proinflammatory mediators (chemokines and adhesion
of inflammatory cell infiltration. molecules) [9, 10, 15, 16].
Conclusions. Ang II in vivo increases TNF- production in Some data suggest that Ang II could regulate TNF-the kidney. Ang II also up-regulates other proinflammatory
production. ACE inhibitors suppress TNF- synthesis bothmediators, including IL-6, MCP-1 and NF-B, coincidentally
associated to the presence of glomerular and interstitial in- in vitro and in vivo [17]. In hypertensive patients, periph-
flammatory cells in the kidney. All these data further strengthen eral blood monocytes are activated presenting elevated
the idea that Ang II plays an active role in the inflammatory levels of proinflammatory cytokines, such as TNF- and
response in renal diseases.
interleukin-1 (IL-1) [18]. In the kidney, TNF- and Ang
II appears to contribute to pathophysiological events
leading to renal fibrosis [14]. Ang II induces TNF- pro-
duction in isolated tubules from rat medullary thick as-
cending limb [19]. In macrophages, Ang II up-regulatesKey words: angiotensin, cytokines, inflammation, kidney, interleukin-1,
TNF- and IL-6 gene expression [20]. In mesangial cellstumor necrosis factor-, monocyte chemoattractant peptide-1, nuclear
factor-B. Ang II increases IL-6 mRNA expression and synthesis
[21], but whether it could regulate TNF- has not been 2002 by the International Society of Nephrology
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addressed. The role of Ang II in the inflammatory re- an anti-CD43 antibody (marker of monocytes, macro-
phages, natural killer cells, and T cells) and DNA-bind-sponse has been recently demonstrated [1]. Ang II pro-
duces several proinflammatory mediators, including adhe- ing activity of transcription factors by Southwestern
histochemistry [24]. The immunostaining was scored bysion molecules and chemokines, and also may modulate
some responses of immune and inflammatory cells, such semiquantitative determination and graded as follows:
0  no staining; 1  mild staining; 2  moderateas chemotaxis, proliferation and the differentiation of
monocytes into macrophages [1]. staining; 3  marked staining [24]. Identification of
different cell types was based on topographical criteria.Systemic Ang II infusion causes renal damage [22–24].
We have previously demonstrated that Ang II increased The mean number of positive cells per glomerular cross
section was determined by evaluating 10 to 15 glomeruli.the activity of the nuclear factor-B (NF-B) in the kid-
ney; however, the NF-B-related genes induced by Ang II The whole interstitium was examined from each animal.
Evaluations were performed by two independent observ-in this organ have not been determined. Our current
study investigated whether Ang II regulates the expres- ers in a blinded fashion, and the mean score value was
calculated for each rat.sion of some NF-B–related cytokines (in particular
TNF-) and chemokines in the kidney.
Cell cultures
Mesangial cells were cultured from isolated rat glo-
METHODS
meruli by sequential sieving and differential centrifuga-
Experimental design tion, and characterized as described [25].
Systemic infusion of Ang II was done into female
RNA studiesWistar rats (subcutaneously by osmotic minipumps; Alza
Corp., Palo Alto, CA, USA), at the dose of 50 ng/kg/ Total RNA was isolated using a standard method with
Trizol reagent (Gibco-BRL, Grand Island, NY, USA)min. Animals were sacrificed at three days (N  8 rats
in each group). Control animals of the same age also and mRNA expression was analyzed by reverse tran-
scription-polymerase chain reaction (RT-PCR) and/orwere studied. Immune complex nephritis was induced
according to a previously described protocol [25]. When Northern blot [25]. DNA probes used were rat MCP-1
[25, 26], rat IP-10 [16], cyclophilin B (CyPB, a gift fromproteinuria appeared, animals were randomly distrib-
uted into two groups: untreated and quinapril-treated SmithKline Beecham) [26] and TNF- [7, 10]. 28S was
used as control of RNA loading. For RT-PCR the specific(ACE inhibitor; 100 mg/L in the drinking water) and
studied three weeks later. primers used were: TNF- (sense: 5-ATGAGCACAG
AAAGCATGATCC-3, antisense: 5-GAAGATGATC
Renal histopathological studies TGAGTGTG-3) [20] and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH; sense: 5-AATGCATCCTGThe presence of cytokines (TNF-, and IL-6) and che-
mokines, monocyte chemoattractant protein-1 (MCP-1) CACCACCAA-3, antisense: 5-GTAGCCATATTCA
TTGTCATA-3), which yields a 251 bp and 515 bp prod-and interferon producing protein-10 (IP-10) were deter-
mined by immunohistochemistry. The antibodies anti- uct, and PCR (1 min at 94, 1 min at 60/54C and 2 min
at 68; 32/25 cycles, respectively).rat TNF- and IL-6 were from Santa Cruz Technology
(tested by Western blot with blocking peptides; Santa
TNF- assayCruz, CA, USA). Paraffin-embedded renal tissue sections
(4 m) were deparaffinized and rehydrated, endogenous Supernatants were tested for the presence of TNF
using a colorimetric assay for L929 cell viability, and re-peroxidase was blocked by incubating in 3% H2O2/meth-
anol (1:1) at 25C for 30 minutes. The slides were sub- sults are calculated as described [6, 7, 27]. Briefly, L929
cells, in 96-well flat-bottomed plates, were incubated forsequently incubated in phosphate-buffered saline (PBS)
with 6% serum in 4% bovine serum albumin (BSA) for 24 hours with three different dilutions of supernatants
containing actinomycin D (1g/mL). Then, medium wasone hour at 37C to reduce nonspecific background stain-
ing, and then incubated overnight at 4C with primary removed and cells were stained with 0.2% crystal violet
in 12% formalin and 10% ethanol. The cells were thenantibodies in PBS containing 1% serum and 4% BSA.
After being washed with PBS, the sections were incu- washed with water and solubilized with ethanol in phos-
phate buffer, and absorbance was measured at 550 nm.bated with secondary antibodies diluted 1:200 in 4%
BSA/PBS for 30 minutes, and after washing, they were Recombinant TNF- standard was also used. The addi-
tion of the anti–TNF- antibody for two hours at 37Crevealed by standard techniques. In each experiment,
negative controls without the primary antibody, or using caused more than an 88% inhibition of the observed
cytolytic effect in the lipopolysaccharide (LPS) samples.an unrelated antibody, were included to check for non-
specific staining. However, this bioassay did not differentiate between the
various forms of TNF (that is, TNF-, TNF-).The inflammatory cell infiltration was evaluated with
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Western blot
Samples from renal cortex were homogenized in lysis
buffer [170 mmol/L Tris-HCl, 22% glycerol, 2.2% so-
dium dodecyl sulfate (SDS), 0.1 mmol/L phenylmethyl-
sulfonyl fluoride (PMSF) and 1g/mL pepstatin A] and
then separated by 12% SDS-polyacrylamide gel electro-
phoresis (SDS-PAGE) under reducing conditions. After
electrophoresis, samples were transferred to polyvinyli-
dene difluoride (PVDF) membranes (Millipore, Bed-
ford, MA, USA). The membranes were blocked in 0.01
mmol/L Tris pH 7.5 and 0.4 mol/L NaCl containing 0.1%
Tween-20, and 5% dry skimmed milk for one hour at
37C, and then incubated in the same buffer with specific
anti–rat TNF- antibody for 18 hours at 4C. After wash-
ing, detection was made by incubation with peroxidase-
conjugated secondary antibody, and developed using an
enhanced chemiluminescence (ECL) kit (Amersham).
Fig. 1. Systemic infusion of angiotensin II (Ang II) increases renal
production of tumor necrosis factor- (TNF-). (A) Rats were infused
Statistical analysis with Ang II (50 ng/kg/min) for 3 days, and total proteins were analyzed.
In control animals no detectable levels of TNF- were found, but inResults are expressed as mean 	 SEM of the experi-
Ang II-infused rats, a band of around 26 kD, corresponding to the
ments made. Significance was established by the Graph- integral transmembrane TNF-was detected. A representative Western
blot shows two different animals of each group; -tubuline was usedPAD Instat using the Student t test (GraphPAD Soft-
as a loading control.ware), Mann Whitney test (non-parametric t test) and
analysis of variance (ANOVA) nonparametric (Kruskal-
Wallis test). Differences were considered significant if mRNA is constitutively expressed by a variety of tissues
the P value was less than 0.05. [29]. By RT-PCR, we have observed that Ang II-infused
rats presented elevated TNF- mRNA levels in the kid-
ney compared to control animals (Fig. 2). We also evalu-RESULTS
ated whether RAS blockers could regulate renal TNF-.
Angiotensin II infusion increases TNF in the kidney In rats with immune-complex nephritis, renal TNF- is
Total proteins from renal cortex were isolated and overexpressed [10]. In this model, we have observed
TNF- protein levels were analyzed by Western blot. In that the ACE inhibitor quinapril diminished proteinuria,
control rats, renal TNF- levels were almost undetect- inflammatory cell infiltration and chemokine overex-
pression [25]. As shown in Figure 2, nephritic animalsable, while samples from Ang II-infused rats showed a
presented elevated renal TNF- mRNA levels that wereband of around 26 kD (Fig. 1A), corresponding to the
diminished by ACE inhibition.apparent molecular weight of integral transmembrane
TNF- molecule, which derives to soluble 17 kD TNF-
Effects of Ang II on TNF mRNA expression andby proteolytic cleavage [15]. The specificity of the anti-
production in cultured mesangial cellsbody was confirmed by competition studies with a block-
ing peptide (not shown). These data demonstrate that Northern blots showed that growth-arrested mesangial
cells expressed low TNF- mRNA levels, as previouslyin vivo Ang II increases renal TNF- production. To
localize the cells responsible for Ang II-induced TNF- described [6]. In mesangial cells treated with Ang II
(10
7 mol/L) for six hours, TNF- mRNA was weaklyoverexpression, immunohistochemistry was done (Fig. 1B).
In controls, TNF- staining was almost unappreciated expressed (Fig. 3). In contrast, in LPS-activated cells
TNF- gene expression was characterized by two hy-as described in human samples [11, 12]. After infusion
of Ang II for three days, a marked increase in TNF- bridizing bands: a strongly hybridizing band and a second
weaker band, which could represent a precursor to thestaining was observed in glomeruli, located in endothelial
cells, and in tubular cells. TNF- positivity also increased main TNF-mRNA [6]. To further investigate this point,
we have measured whether Ang II could stimulate TNF-in renal arteries, in both endothelial and vascular smooth
muscle cells. The controls of the technique are shown in production. Mesangial cells were incubated with Ang II
(10
7 to 10
10 mol/L) from 0 to 24 hours, conditionedFigure 1C. The semiquantitative score, determined as
described in the Methods section, is shown in Figure 1D. media was collected and TNF- bioactivity was deter-
mined by L929 bioassay. LPS (1 g/mL) was used asThe biosynthesis of TNF- is believed to be regulated
primarily at the translational level [28], because TNF- positive control [6, 27]. As shown in Figure 3, at different
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Fig. 1. (Continued) (B) Localization of TNF-
immunostaining in Ang II-infused rats. In con-
trol rats, TNF- staining was almost undetect-
able in the glomeruli and renal arteries, and
was weak in the renal tubules. In Ang II-infused
rats at day 3, TNF immunostaining was clearly
shown in the glomerulus (localized to endo-
thelial cells; arrow) and renal arteries (mainly
in endothelial cells; arrow). There was a marked
increase in the cytosolic staining of renal tu-
bules following Ang II infusion (arrowhead).
(Magnification, 200 and 400).
time points studied there were no differences between immunoreactive TNF- that was bound by soluble TNF-
receptors and hence biologically inactive.control and Ang II-treated mesangial cells, while in LPS-
stimulated cells TNF-–dependent cytotoxicity was in-
Ang II in vivo increases renal cytokine andcreased from three to nine hours, and decreased progres-
chemokine productionsively thereafter. These data show that Ang II did not
increase TNF- bioactivity in mesangial cells. Since TNF- We also evaluated the expression of other cytokines
and chemokines in the kidney of these animals usingproduction was measured using a bioassay, we could not
exclude the possibility that Ang II increased levels of immunohistochemistry. As shown in Figure 4, in rats in-
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Fig. 1. (Continued) (C ) The negative con-
trol of the immunostaining, as described in
Methods section. Magnification, 200. (D)
Semiquantitative score of TNF- immuno-
staining in renal tissue. Symbols are: () con-
trol animals, () animals infused with Ang II
for 3 days. Results are means 	 SEM of 8
animals per group. *P  0.05 vs. control.
and renal arteries (located mainly in vascular smooth
muscle cells). Some chemokines also were evaluated;
MCP-1 was markedly up-regulated in glomerular and
tubular cells of Ang II-infused rats, while IP-10 immuno-
staining was not modified (Fig. 5).
Systemic infusion of Ang II for three days into normal
rats caused a slight elevation in blood pressure within
the normotensive range (121 	 9 mm Hg, compared to
100 	 2 in controls; P  0.05, N  8). These animals
presented activated NF-B complexes located mainly in
the glomeruli (mesangial, endothelial and epithelial cells),
and in tubulointerstitial areas (Fig. 5), as previously de-
scribed [24]. In Ang II-infused rats the presence of in-
flammatory cells (CD43 positive cells) in glomeruli and
in tubulointerstitial areas was also observed (Fig. 5), butFig. 2. Systemic infusion of Ang II increases renal TNF- mRNA
expression (left). Ang II (50 ng/kg/min; N  8) was infused into rats fibrosis was not found (not shown), as described [22–24].
for 3 days, and the total cortex RNA was extracted and analyzed by RT- These data show a correlation between cytokine andPCR. (Right) ACE inhibition diminishes renal TNF- overexpression in
chemokine overexpression, activation of NF-B and thea normotensive model of immune-complex nephritis in rats. Total cortex
RNA was analyzed by RT-PCR. Some animals were treated with the presence of inflammatory cells in the kidney of Ang II-
ACE inhibitor quinapril (100 mg/L; N  8). A representative RT-PCR infused rats.experiment of one animal from each group is shown. GAPDH gene
expression was used as control.
Ang II up-regulates chemokine mRNA expression in
rat mesangial cells
Renal cells can produce cytokines and chemokines infused with Ang II for three days there was a marked
increase in IL-6 immunostaining, mainly in glomeruli response to different stimuli, such as LPS and TNF- [6,
10, 16, 26]. By Northern blot, we have studied in mesan-(mesangial, endothelial and epithelial cells), some tubuli
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and puromycin nephrosis [7, 10, 14]. In some patients
with renal diseases, elevated TNF- levels in serum or
supernatants from peripheral blood mononuclear cells
have also been described [10]. Some data suggest a po-
tential relation between Ang II and TNF- during renal
injury. Treatment with ACE inhibitors is associated with
lower plasma TNF- in patients with advanced chronic
renal failure [13]. In renal damage induced by endotoxe-
mia, RAS inhibitors completely suppressed LPS-induced
IL-6 and TNF- mRNA levels in the kidney [30]. In rats
with immune complex nephritis, we have observed that
renal overexpression of TNF- was diminished by the
ACE inhibitor quinapril. A previous study has shown
that Ang II increased TNF- production in isolated tu-
bules from rat medullary thick ascending limb [19]. We
have observed that tubular cells from Ang II-infused
rats presented elevated TNF- immunostaining, demon-
strating that in vivo Ang II increased TNF- production
in tubular cells. Although in mesangial cells several fac-
tors elicit the synthesis of TNF-, we did not find a sig-
nificant increase in TNF- release in response to Ang II,
neither in vivo nor in vitro. Since Ang-II induces prosta-
glandin E2 (PGE2) production, and PGE2 inhibits LPS-
stimulated TNF- release [9], this could be a potential
explanation for this negative result.
We have observed that in Ang II-infused rats, TNF-
is expressed in glomerular endothelial cells and renal
arteries. By immunohistochemistry high levels of TNF-
have been found in endothelial cells of human atheroma
plaques [31]. Some data suggest that endothelial cells
Fig. 3. Regulation of TNF- by Ang II in mesangial cells. (A) Growth-
can produce TNF-. In human umbilical vein endothelialarrested mesangial cells were stimulated with 10
7 mol/L Ang II for 6
hours. A known TNF- activator, 1 g/mL lipopolysaccharide (LPS) cells, LPS or IL-1 induced, in a dose-dependent manner,
was used. A representative Northern blot of two experiments is shown, TNF- mRNA, but only IL-1 produced TNF- protein
with 28S as the loading control. (B) TNF- production after stimulation
[8]. Most of the TNF- protein in cell lysates was foundwith Ang II and LPS. Mesangial cells were stimulated by indicated
in the membrane fraction. In paraformaldehyde-fixed en-times and TNF- production in supernatants was determined using the
cytotoxic activity assay on L929 cells. Symbols are: () control; () dothelial cells a diffuse pattern over the cell surface was
LPS; ( ) 10
7 mol/L Ang II; ( ) 10
10 mol/L Ang II. Data are means 	 observed by fluorescence, suggesting that TNF- maySEM for 6 experiments. *P  0.05 vs. control.
be anchored in the membrane or may be processed and
bound back to the cell surface [8]. The transmembrane
gial cells the effect of Ang II on the gene expression of form of TNF- is reported to be superior to soluble
some chemokines. Stimulation of mesangial cells with TNF- in T-cell activation, thymocyte proliferation, and
Ang II for six hours increased mRNA levels of MCP-1, production of granulocyte-macrophage colony-stimulat-
CyPB (3- and 2-fold vs. control, respectively), but not ing factor [32]. By Western blot in renal samples from
Ang II-infused rats we have detected the 26 kD TNF-IP-10 (Fig. 6). As a positive control recombinant human
corresponding to transmembrane form. Our data suggestTNF- (100 U/mL) was used.
that in response to Ang II, renal endothelial cells can
produce TNF- that may act in a juxtacrine fashion to
DISCUSSION activate target cells on the endothelial surface. In addi-
Our current study demonstrates that infusion of Ang tion, secreted TNF- may be involved in the autocrine
II for three days caused an elevation in renal production activation of neighboring cells. Therefore, TNF- may
of TNF-. The role of TNF- during renal injury has mediate, in part, the inflammatory responses elicited by
already been demonstrated [7, 10, 14]. Elevated renal Ang II in endothelial cells.
mRNA expression, glomerular and tubular production, Interactions between TNF- and Ang II are not lim-
and urine TNF- levels have been found in several mod- ited to the kidney. In Ang II-induced hypertension anti-
els of renal injury, including immune-complex nephritis, TNF antisera increases mean arterial pressure, sug-
gesting that TNF- participates in a counter-regulatorylupus nephritis, anti-glomerular basement membrane
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Fig. 4. Systemic infusion of Ang II increases
renal production of IL-6. (A) Photomicro-
graphs show representative immunostaining
of kidney sections of control and an Ang II-
infused rat for 3 days, which were stained with
a specific antibody to rat IL-6. In control rats,
IL-6 staining was almost undetectable. There
was no staining in the negative controls in-
cluded in each experiment (not shown). (Mag-
nification100) (B) Semiquantitative score of
IL-6 immunostaining. Symbols are () control
animals; () animals infused with Ang II for
3 days. Results are means	 SEM of 6 animals
per group. *P  0.05 vs. control.
mechanism that opposes the pressor effects of Ang II [33]. Interleukin-6 is a multifunctional cytokine exerting a
It is now well established that activation of the circulating wide variety of biologic responses that participate in the
and tissue RAS is involved in the pathophysiology of pathogenesis of mesangial proliferative glomerulonephri-
heart failure. In patients with end-stage cardiac disease, tis [39]. Ang II increased IL-6 release and mRNA ex-
circulating TNF- concentrations are increased associ- pression in cultured mesangial and vascular smooth mus-
ated with marked activation of RAS [34]. Recent reports cle cells [21, 40]. We have observed that Ang II-infused
have demonstrated that the cardiac myocyte may be an rats presented elevated production of IL-6, expressed in
important source of TNF- production in response to LPS glomerular cells (mainly in mesangial cells), tubular cells
stimulation or pressure overloading [35, 36]. In cardiac and renal arteries (mainly in vascular smooth muscle
fibroblasts, but not in myocytes, Ang II stimulates TNF-
cells), demonstrating that Ang II in vivo increases IL-6mRNA expression and the production of biologically
production. The blockade of IL-6 signaling with anti–IL-6active TNF- [37]. However, the amount of TNF- pro-
receptor antibody abolished Ang II-induced cell prolifer-duced by stimulation with Ang II was less than that
ation [21]. Ang II also regulates the production of severalinduced by LPS. The TNF- level elicited by stimulation
growth factors, such as transforming growth factor-with Ang II was similar to the TNF- concentrations re-
(TGF-), connective tissue growth factor (CTGF), para-ported in various human cardiac diseases [34, 38]. All these
thyroid hormone-related protein (PTHrP) involved indata suggest that TNF- production in cardiac fibroblasts
cell growth and extracellular matrix accumulation regu-may act on cardiac myocytes in a paracrine fashion in the
setting of congestive heart failure or cardiac hypertrophy. lation [3, 41]. Thus, some effects of Ang II may be medi-
Fig. 5. Ang II-infused rats presented elevated renal production of chemokines, activation of the transcription factor NF-B, and the presence of
inflammatory cells. Rats were infused with Ang II (50 ng/kg/min) for 3 days. Photomicrographs show a representative immunostaining of kidney
sections with specific antibodies to rat MCP-1 and IP-10. In control rats, no staining for chemokines was found. Control animals did not present
staining for NF-B. After Ang II infusion a clear nuclear staining for NF-B was seen in the glomeruli, located in mesangial, epithelial and
endothelial cells. Ang II-infused animals had inflammatory cells expressing CD43 antigen in glomeruli and interstitium, distributed in a focal
manner. There was no staining in the negative controls included in each experiment (not shown). Figures show a representative animal of each
group of four studied.
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elicited the synthesis of the chemokine RANTES (nor-
mal T cell expressed/secreted) [23] and in vascular smooth
muscle cells the mRNA expression of IL-8 and IP-10 [1].
In vivo, Ang II infusion into normal rats increased glo-
merular expression of RANTES [23] and tubular over-
expression of osteopontin (OPN) [44]. Renal IP-10 over-
expression has been found in renal diseases [16], but, at
least at times and doses employed in our study, Ang II
did not regulate IP-10 in vivo and in cultured mesangial
cells. CypB is a cyclosporine A (CsA)-binding protein
that exhibits chemotactic activity for polymorphonuclear
leukocytes and monocytes [45]. Elevated levels of CyPB
have been found in proximal tubules of hypertensive rats
[46], renal interstitial fibroblasts in response to MCP-1
and IP-10 [26], and in mesangial cells stimulated with
Ang II, as described in our current study. All these data
strongly suggest that Ang II, through the chemokine
production by resident renal cells, may play a central
role in the regulation of inflammatory cell recruitment
in renal pathology.
The NF-B pathway plays an important role in the
progression of kidney damage [47]. Emerging data suggest
a potential role of NF-B as a mediator of Ang II-induced
inflammatory process. Ang II increases proinflammatory
genes under NF-B control, including cytokines (IL-6,
and as shown in this study, TNF-), chemokines (MCP-1
and RANTES), adhesion molecules and angiotensinogen
[1]. We have observed that systemic infusion of Ang IIFig. 6. Effects of Ang II on mRNA expression of chemokines in rat
mesangial cells. Quiescent cells were treated with 10
7 mol/L Ang II for caused NF-B activation associated with overexpression
6 hours, and gene expression of MCP-1, CyPB and IP-10 was analyzed by of cytokines (TNF- and IL-6) and chemokines (MCP-1).Northern blot. As positive control TNF (100 U/mL) was used. 28S was
In some models of renal injury, ACE inhibitors dimin-used as an internal control. A representative Northern blot of 3 different
experiments is shown. ished renal NF-B activity, chemokines (MCP-1, RANTES
and OPN) and adhesion molecules, correlated with a
diminution in the mononuclear cell infiltration in the
kidney [1]. In this sense, we have observed that quinapril
ated, either directly or indirectly, by cytokines produced diminished renal TNF-. Another ACE inhibitor, enala-
in response to this peptide. pril, protects from pulmonary hypertension by inhibiting
The recruitment of monocyte-macrophages plays a TNF-–mediated activation of NF-B [48]. These data
crucial role in the onset and progression to irreversible are consistent with a role for NF-B in transcriptional
structural renal changes [1]. Ang II induces the produc- activation of those genes, as shown in cultured cells [47].
tion of chemotactic factors by resident renal cells. We Depending on the cell type, different Ang II receptors
have observed that in Ang II-infused rats MCP-1 staining are involved in NF-B pathway [1]. Moreover, AT1 and
was increased in glomeruli and tubular cells. In cultured AT2 receptors seem to participate in the inflammatory
mesangial cells, we have previously observed that Ang II response in renal and vascular tissues. In this regard,
is a potent activator of MCP-1, with a magnitude compa- future studies are needed to define the Ang II receptor
rable to inflammatory cytokines [25]. Interestingly, an subtypes implicated in gene/NF-B regulation in each
anti–MCP-1 antibody did not completely block the che- tissue and pathological condition.
motactic effects of Ang II [42], suggesting that other On the whole, Ang II infusion into normal rats causes
chemokines may be involved. RAS blockers also dimin- elevation of renal production of TNF- and other pro-
ished the expression of several chemokines in damaged inflammatory mediators, including IL-6 and MCP-1, and
vessels and kidney. Thus, in a model of atherosclerosis activation of the transcription factor NF-B associated
ACE inhibitors decreased IL-8 [1]. Fractalkine, a novel with the presence of inflammatory cells. Our data show
CX3X chemoattractant and adhesion molecule, was di- that Ang II acts as a true cytokine regulating many fac-
minished by AT1 antagonist in uninephrectomized anti- tors that contribute to the inflammatory response in renal
diseases.Thy nephritis [43]. Ang II in glomerular endothelial cells
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